A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease

J Gerber1, G Raivich, A Wellmer

  • 1Department of Neurology, University of Göttingen, Germany.

Acta Neuropathologica
|August 4, 2001
PubMed

Insights

Early ceftriaxone treatment saves mice from fatal Streptococcus pneumoniae meningitis. Prompt intervention prevents severe bacterial infection, inflammation, and neuronal damage, highlighting the importance of timely antibiotic therapy.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Immunology

Background:

  • Streptococcus pneumoniae meningitis is a severe infection causing significant morbidity and mortality.
  • Understanding the progression of meningitis and its neurological consequences is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the course of bacterial meningitis, inflammation, and neuronal damage in a mouse model.
  • To evaluate the efficacy of ceftriaxone treatment at different time points post-infection.

Main Methods:

  • Establishment of a mouse model by intracerebral injection of Streptococcus pneumoniae.
  • Monitoring of bacterial titers, meningeal inflammation, behavioral changes, and neuronal damage.
  • Assessment of treatment effects with ceftriaxone at various intervals.

Main Results:

  • S. pneumoniae infection led to high bacterial titers, severe meningeal inflammation, and widespread neuronal damage.
  • Intercellular cell adhesion molecule-1 and macrophage colony-stimulating factor deficiency did not alter disease severity.
  • Early ceftriaxone treatment (before 24 hours) resulted in survival and absence of behavioral abnormalities.
  • Delayed treatment (after 30 hours) led to over 50% mortality.

Conclusions:

  • The developed mouse model accurately reflects human meningitis pathology and is suitable for therapeutic studies.
  • Timely antibiotic intervention is critical for successful treatment outcomes in bacterial meningitis.
  • The study underscores the importance of early diagnosis and treatment initiation for S. pneumoniae meningitis.